Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

European Journal of Pharmacology

Volumn 401, Issue 3, 2000, Pages 259-270

  Kintscher, Ulrich ^a,b   Goetze, Stephan ^b   Wakino, Shu ^a   Kim, Sarah ^a   Nagpal, Sunil ^c   Chandraratna, Roshantha A S ^c   Graf, Kristof ^b   Fleck, Eckart ^b   Hsueh, Willa A ^a   Law, Ronald E ^a  

^a ROSS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c ALLERGAN INC   (United States)

Author keywords

Inflammation; Matrix metalloproteinase; Migration; Monocyte; Peroxisome proliferator activated receptor (PPAR); Retinoid X receptor (RXR)

Indexed keywords

5,8,11,14 ICOSATETRAYNOIC ACID; AGN 4204; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; RETINOID X RECEPTOR; ROSIGLITAZONE; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CHEMOLUMINESCENCE; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; LEUKOCYTE MIGRATION INHIBITION TEST; MONOCYTE; PRIORITY JOURNAL;

5,8,11,14-EICOSATETRAYNOIC ACID; CELL MOVEMENT; CHEMOKINE CCL2; CHEMOTAXIS; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; TETRADECANOYLPHORBOL ACETATE; THIAZOLES; THIAZOLIDINEDIONES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034637218     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00461-1     Document Type: Article

References (47)

1. Adams D.H., Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet. 343:1994;831-836.
2. Allenby G., Janocha R., Kazmer S., Speck J., Grippo J.F., Levin A.A. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid. J. Biol. Chem. 269:1994;16689-16695.
3. Bevilacqua M.P., Nelson R.M., Mannori G., Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annu. Rev. Med. 45:1994;361-378.
4. Bond M., Fabunmi R.P., Baker A.H., Newby A.C. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 435:1998;29-34.
5. Campbell E.J., Cury J.D., Shapiro S.D., Goldberg G.I., Welgus H.G. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J. Immunol. 146:1991;1286-1293.
6. Chinetti G., Griglio S., Antonucci M., Torra I.P., Delerive P., Majd Z., Fruchart J.C., Chapman J., Najib J., Staels B. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273:1998;25573-25580.
7. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J.M., Gonzalez F.J., Fruchart J.C., Tedgui A., Haegeman G., Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274:1999;32048-32054.
8. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:1999;649-688.
9. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature. 384:1996;39-43.
10. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:1994;2493-2503.
11. Goetze S., Xi X.P., Kawano H., Gotlibowski T., Fleck E., Hsueh W.A., Law R.E. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 33:1999;798-806.
12. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol. 74:1997;111-122.
13. Graf K., Xi X.P., Yang D., Fleck E., Hsueh W.A., Law R.E. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 29:1997;334-339.
14. Gum R., Wang H., Lengyel E., Juarez J., Boyd D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene. 14:1997;1481-1493.
15. Jackson S.M., Parhami F., Xi X.P., Berliner J.A., Hsueh W.A., Law R.E., Demer L.L. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler. Thromb. Vasc. Biol. 19:1999;2094-2104.
16. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:1998;82-86.
17. Johnson B.S., Chandraratna R.A., Heyman R.A., Allegretto E.A., Mueller L., Collins S.J. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. Mol. Cell. Biol. 19:1999;3372-3382.
18. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of 9-cis-retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 358:1992;771-774.
19. Konttinen Y.T., Ainola M., Valleala H., Ma J., Ida H., Mandelin J., Kinne R.W., Santavirta S., Sorsa T., Lopez-Otin C., Takagi M. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis. 58:1999;691-697.
20. Kundra V., Anand-Apte B., Feig L.A., Zetter B.R. The chemotactic response to PDGF-BB: evidence of a role for Ras. J. Cell. Biol. 130:1995;725-731.
21. Kuziel W.A., Morgan S.J., Dawson T.C., Griffin S., Smithies O., Ley K., Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12053-12058.
22. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187:1998;601-608.
23. Mangelsdorf D.J., Borgmeyer U., Heyman R.A., Zhou J.Y., Ong E.S., Oro A.E., Kakizuka A., Evans R.M. Characterization of three RXR genes that mediate the action of 9-cis-retinoic acid. Genes Dev. 6:1992;329-344.
24. Marx N., Schonbeck U., Lazar M.A., Libby P., Plutzky J. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res. 83:1998;1097-1103.
25. Marx N., Sukhova G., Murphy C., Libby P., Plutzky J. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153:1998;17-23.
26. Murao K., Imachi H., Momoi A., Sayo Y., Hosokawa H., Sato M., Ishida T., Takahara J. Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells. FEBS Lett. 454:1999;27-30.
27. Na S.Y., Kang B.Y., Chung S.W., Han S.J., Ma X., Trinchieri G., Im S.Y., Lee J.W., Kim T.S. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J. Biol. Chem. 274:1999;7674-7680.
28. Nelken N.A., Coughlin S.R., Gordon D., Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1991;1121-1127.
29. Pasceri V., Wu H.D., Willerson J.T., Yeh E.T. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation. 101:2000;235-238.
30. Poynter M.E., Daynes R.A. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 273:1998;32833-32841.
31. Reddy K.B., Krueger J.S., Kondapaka S.B., Diglio C.A. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int. J. Cancer. 82:1999;268-273.
32. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
33. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
34. Salbert G., Fanjul A., Piedrafita F.J., Lu X.P., Kim S.J., Tran P., Pfahl M. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity. Mol. Endocrinol. 7:1993;1347-1356.
35. Simmons K.M., Brown K.A., Kirk A.P., Perry J.D., Dumonde D.C. Enhanced chemotaxis of monocytes in rheumatoid arthritis. Br. J. Rheumatol. 26:1987;245-250.
36. Strieter R.M., Wiggins R., Phan S.H., Wharram B.L., Showell H.J., Remick D.G., Chensue S.W., Kunkel S.L. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem. Biophys. Res. Commun. 162:1989;694-700.
37. Su C.G., Wen X., Bailey S.T., Jiang W., Rangwala S.M., Keilbaugh S.A., Flanigan A., Murthy S., Lazar M.A., Wu G.D. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 104:1999;383-389.
38. Taubman M.B., Rollins B.J., Poon M., Marmur J., Green R.S., Berk B.C., Nadal-Ginard B. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ. Res. 70:1992;314-325.
39. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
40. Villiger P.M., Terkeltaub R., Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J. Immunol. 149:1992;722-727.
41. Wahba A., Cohen H.A., Bar-Eli M., Gallily R. Enhanced chemotactic and phagocytic activities of leukocytes in psoriasis vulgaris. J. Invest. Dermatol. 71:1978;186-188.
42. Watanabe H., Nakanishi I., Yamashita K., Hayakawa T., Okada Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J. Cell. Sci. 104:1993;991-999.
43. Welgus H.G., Campbell E.J., Cury J.D., Eisen A.Z., Senior R.M., Wilhelm S.M., Goldberg G.I. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86:1990;1496-1502.
44. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. Faseb. J. 13:1999;781-792.
45. Yamaguchi K., Groopman J.E., Byrn R.A. The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors. AIDS. 8:1994;1675-1682.
46. Zeigler M.E., Chi Y., Schmidt T., Varani J. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J. Cell. Physiol. 180:1999;271-284.
47. Zhu L., Bisgaier C.L., Aviram M., Newton R.S. 9-cis-retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;2105-2111.